ClinicalTrials.Veeva

Menu

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life (CONQUER)

A

Aarhus University Hospital

Status

Invitation-only

Conditions

Bladder Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05195515
CONQUER

Details and patient eligibility

About

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
  • Ability to understand written and oral Danish

Exclusion criteria

  • Known Alzheimers disease
  • Diagnosed other causes explaining the hematuria

Trial contacts and locations

5

Loading...

Central trial contact

Jørgen Bjerggaard Jensen, Professor MD; Rikke Vilsbøll Milling, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems